In these reports, the autoantibodies induced by ICI therapy that could be associated with myositis and myocarditis are anti-acetylcholine receptors, anti-striated muscle antibodies, anti-mitochondrial antibodies, anti-alanyl-tRNA synthetase, anti-signal recognition particle (SRP) antibodies, and anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase (Supplementary Table S4). This evidence concerns the gene HMGCR and myositis disease.